Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7

Journal of Pharmacological Sciences

Volumn 117, Issue 3, 2011, Pages 189-203

  Inden, Masatoshi ^a,e   Kitamura, Yoshihisa ^a   Takahashi, Kazunori ^b   Takata, Kazuyuki ^a   Ito, Natsuko ^a   Niwa, Rina ^a   Funayama, Risa ^a   Nishimura, Kaneyasu ^a   Taniguchi, Takashi ^a   Honda, Toshio ^b   Taira, Takahiro ^c   Ariga, Hiroyoshi ^d  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

6 hydroxydopamine; DJ 1; Neuroprotection; Parkinson's disease; Rotenone

Indexed keywords

2 [3 (BENZYLOXY) 4 METHOXYPHENYL] N [2 (7 METHOXY 1,3 BENZODIOXOL 5 YL)ETHYL]ACETAMIDE; ALPHA SYNUCLEIN; ANTIPARKINSON AGENT; DJ 1 PROTEIN; REACTIVE OXYGEN METABOLITE; UCP 0054278; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; GLIA CELL; HUMAN CELL CULTURE; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROINJECTION; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; RAT;

EID: 81455155546     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11151FP     Document Type: Article

References (52)

1. Dunnett SB, Björklund A. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature. 1999;399 Suppl:A32-A39.
2. Shimohama S, Sawada H, Kitamura Y, Taniguchi T. Disease model: Parkinson's disease. Trends Mol Med. 2003;9:360-365. (Pubitemid 37040032)
3. Parker WD Jr, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol. 1989;26:719-723. (Pubitemid 20011004)
4. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet. 1989;3:1269. (Pubitemid 19140359)
5. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AH, Marsden CD. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain. 1992;115:333-342.
6. Mizuno Y, Yoshino H, Ikebe S, Hattori N, Kobayashi T, Shimoda-Matsubayashi S, et al. Mitochondrial dysfunction in Parkinson's disease. Ann Neurol. 1998;44:S99-S109. (Pubitemid 28423835)
7. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997;276:2045-2047. (Pubitemid 27443610)
8. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392:605-608. (Pubitemid 28207717)
9. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, et al. The ubiquitin pathway in Parkinson's disease. Nature. 1998;395:451-452.
10. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003;299:256-259. (Pubitemid 36131051)
11. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 2004;304:1158-1160. (Pubitemid 38661852)
12. Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron. 2004;44:595-600. (Pubitemid 39531224)
13. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44:601-607. (Pubitemid 39531225)
14. Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SMM, et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commum. 1997;231:509-513. (Pubitemid 27214343)
15. Takahashi K, Taira T, Niki T, Seino C, Iguchi-Ariga SMM, Ariga H. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J Biol Chem. 2001;276:37556-37563.
16. Niki T, Takahashi-Niki K, Taira T, Iguchi-Ariga SMM, Ariga H. DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. Mol Cancer Res. 2003;1:247-261. (Pubitemid 36292610)
17. Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H, Mizusawa H. Down-regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun. 2003;312:1342-1348. (Pubitemid 37490964)
18. Taira T, Saito Y, Niki T, Iguchi-Ariga SMM, Takahashi K, Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 2005;5:213-218.
19. Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, Bandyopadhyay S, et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci U S A. 2004;101:9103-9108. (Pubitemid 38781618)
20. Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A. DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol. 2004;2:e362.
21. Martinat C, Shendelman S, Jonason A, Leete T, Beal MF, Yang L, et al. Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES-derived cell model of primary parkinsonism. PLoS Biol. 2004;2:e327.
22. Shinbo Y, Taira T, Niki T, Iguchi-Ariga SMM, Ariga H. DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. Int J Oncol. 2005;26:641-648.
23. Shinbo Y, Niki T, Taira T, Ooe H, Takahashi-Niki K, Maita C, et al. Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities. Cell Death Diff. 2006;13:96-108.
24. 2-induced cell death. Free Radic Res. 2006;40:155-165.
25. Xu J, Zhong N, Wang H, Elias JE, Kim CY, Woldman I, et al. The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Hum Mol Genet. 2005;14:1231-1241. (Pubitemid 40613911)
26. Fan J, Ren H, Ji N, Fei E, Zhou T, Jiang P, et al. DJ-1 decreases bax expression through repressing p53 transcriptional activity. J Biol Chem. 2008;283:4022-4030.
27. Junn E, Jang WH, Zhao X, Jeong BS, Mouradian MM. Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. J Neurosci Res. 2009;87:123-129.
28. Ishikawa S, Taira T, Niki T, Takahashi-Niki K, Maita C, Maita H, et al. Oxidative status of DJ-1-dependent activation of dopamine synthesis through interaction of tyrosine hydroxylase and 4-dihydroxy-L-phenylalamine (L-DOPA) decarboxylase with DJ-1. J Biol Chem. 2009;284:28832-28844.
29. Ishikawa S, Taira T, Niki T, Takahashi-Niki K, Ariga H, Iguchi-Ariga SM. Human DJ-1-specific transcriptional activation of tyrosine hydroxylase gene. J Biol Chem. 2010;285:39718-39731.
30. Inden M, Taira T, Kitamura Y, Yanagida T, Tsuchiya D, Takata K, et al. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neurobiol Dis. 2006;24:144-158. (Pubitemid 44416214)
31. Yanagisawa D, Kitamura Y, Inden M, Takata T, Taniguchi T, Morikawa S, et al. DJ-1 protects against neurodegeneration caused by focal cerebral ischemia and reperfusion in rats. J Cereb Blood Flow Metab. 2008;28:563-578. (Pubitemid 351304267)
32. Miyazaki S, Yanagida T, Nunome K, Ishikawa S, Inden M, Kitamura Y, et al. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats. J Neurochem. 2008;105:2418-2434. (Pubitemid 351782268)
33. Yamane K, Kitamura Y, Yanagida T, Takata K, Yanagisawa D, Taniguchi T, et al. Oxidative neurodegeneration is prevented by UCP0045037, an allosteric modulator for the reduced form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7. Int J Mol Sci. 2009;10:4789-4804.
34. Yanagida T, Kitamura Y, Yamane K, Takahashi K, Takata K, Yanagisawa D, et al. Protection against oxidative stress-induced neurodegeneration by a modulator for DJ-1, the wild-type of familial Parkinson's disease-linked PARK7. J Pharmacol Sci. 2009;109:463-468.
35. Yanagida T, Tsushima J, Kitamura Y, Yanagisawa D, Takata K, Shibaike T, et al. Oxidative stress induction of DJ-1 protein in reactive astrocytes scavenges free radicals and reduces cell injury. Oxid Med Cell Longev. 2009;2:36-42.
36. Kinumi T, Kimata J, Taira T, Ariga H, Niki E. Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2004;317:722-728. (Pubitemid 38481432)
37. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand. 1971;Suppl 367:69-93.
38. Inden M, Kitamura Y, Takeuchi H, Yanagida T, Takata K, Kobayashi Y, et al. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. J Neurochem. 2007;101:1491-1504. (Pubitemid 46848844)
39. Inden M, Kitamura Y, Abe M, Tamaki A, Takata K, Taniguchi T. Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL/6 mice. Biol Pharm Bull. 2011;34:92-96.
40. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and patholigic brain. Nat Neurosci. 2007;10:1387-1394. (Pubitemid 350014685)
41. Kitamura Y, Nomura Y. Stress proteins and glial functions: possible therapeutic targets for disorders. Pharmacol Ther. 2003;97:35-53. (Pubitemid 35477803)
42. Kitamura Y, Kosaka T, Kakimura J, Matsuoka Y, Kohno Y, Nomura Y, et al. Protective effects of antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells. Mol Pharmacol. 1998;54:1046-1054. (Pubitemid 29002048)
43. Zhou W, Zhu M, Wilson MA, Petsko GA, Fink AL. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J Mol Biol. 2006;356:1036-1048. (Pubitemid 43145955)
44. Allard L, Burkhard PR, Lescuyer P, Burgess JA, Walter N, Hochstrasser DF, et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem. 2005;51:2043-2051. (Pubitemid 41532619)
45. Waragai M, Wei J, Fujita M, Nakai M, Ho G, Masliah E, et al. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. Biochem Biophys Res Commun. 2006;345:967-972. (Pubitemid 43776502)
46. Hayashi T, Ishimori C, Takahashi-Niki K, Taira T, Kim YC, Maita H, et al. DJ-1 binds to mitochondrial complex I and maintains its activity. Biochem Biophys Res Commun. 2009;390:667-672.
47. Blackinton J, Lakshminarasimhan M, Thomas KJ, Ahmad R, Greggio E, Raza AS, et al. Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1. J Biol Chem. 2009;284:6476-6485.
48. Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT, et al. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature. 2010;468:696-700.
49. Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP. DJ-1, a cancer-and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci U S A. 2006;103:15091-15096. (Pubitemid 44583169)
50. Junn E, Taniguchi H, Jeong BS, Zhao X, Ichijo H, Mouradian MM. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci U S A. 2005;102:9691-9696. (Pubitemid 40981742)
51. Thomas KJ, McCoy MK, Blackinton J, Beilina A, van der Brug M, Sandebring A, et al. DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Hum Mol Genet. 2011;20:40-50.
52. McCoy MK, Cookson MR. DJ-1 regulation of mitochondrial function and autophagy through oxidative stress. Autophagy. 2011;7:531-532.